Tharimmune, INC Schedule 13G passive stakes

ARK Investment Management LLC and Catherine D. Wood have jointly filed a Schedule 13G, reporting beneficial ownership of 4.74% of Canton Strategic Holdings, Inc. common stock as of June 30, 2026.

A group of investors led by Murtaza S. Akbar and Emil Woods disclosed a 9.99% beneficial ownership stake in Canton Strategic Holdings, Inc. via a Schedule 13G filing.

Broadridge Financial Solutions, Inc. has reported a 9.99% beneficial ownership stake in THARIMMUNE, INC., primarily through warrants.

ARK Investment Management LLC and Catherine D. Wood have jointly disclosed a beneficial ownership of 8.92% in Tharimmune, Inc. common stock.

LCV Funds and related entities have reported a beneficial ownership of approximately 9.99% in Tharimmune, Inc., primarily through common stock and exercisable warrants.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 2.2% of THARIMMUNE INC's common stock as of December 31, 2025.

BlackRock, Inc. has reported a 9.8% beneficial ownership stake in THARIMMUNE INC, holding 663,882 shares of common stock.

GSB Holdings, Inc., David Howard Clarke, and Bounty Hunter LLC have disclosed beneficial ownership of Tharimmune, Inc. common stock, with Mr. Clarke holding a 9.4% stake.